Merck & Co., Inc. Quarterly Intangible Assets, Net (Excluding Goodwill) in USD from Q1 2010 to Q4 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.
Summary: Merck & Co., Inc. quarterly Intangible Assets, Net (Excluding Goodwill) history and growth rate from Q1 2010 to Q4 2024.
Merck & Co., Inc. Intangible Assets, Net (Excluding Goodwill) for the quarter ending December 31, 2024 was $16.4B, a 9.11% decline year-over-year.

Intangible Assets, Net (Excluding Goodwill), Quarterly (USD)

Intangible Assets, Net (Excluding Goodwill), YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2024	$16.4B	-$1.64B	-9.11%	Dec 31, 2024	10-K	2025-02-25
Q3 2024	$17B	-$2.19B	-11.4%	Sep 30, 2024	10-Q	2024-11-06
Q2 2024	$17B	-$2.68B	-13.6%	Jun 30, 2024	10-Q	2024-08-05
Q1 2024	$17.6B	-$2.29B	-11.5%	Mar 31, 2024	10-Q	2024-05-03
Q4 2023	$18B	-$2.26B	-11.1%	Dec 31, 2023	10-K	2025-02-25
Q3 2023	$19.2B	-$2.17B	-10.2%	Sep 30, 2023	10-Q	2023-11-03
Q2 2023	$19.7B	-$2.83B	-12.6%	Jun 30, 2023	10-Q	2023-08-07
Q1 2023	$19.9B	-$3.17B	-13.7%	Mar 31, 2023	10-Q	2023-05-05
Q4 2022	$20.3B	-$2.66B	-11.6%	Dec 31, 2022	10-K	2024-02-26
Q3 2022	$21.4B	+$7.98B	+59.7%	Sep 30, 2022	10-Q	2022-11-03
Q2 2022	$22.5B	+$8.88B	+65.2%	Jun 30, 2022	10-Q	2022-08-05
Q1 2022	$23B	+$8.62B	+59.9%	Mar 31, 2022	10-Q	2022-05-05
Q4 2021	$22.9B	+$8.83B	+62.6%	Dec 31, 2021	10-K	2023-02-24
Q3 2021	$13.4B	-$3.29B	-19.7%	Sep 30, 2021	10-Q	2021-11-05
Q2 2021	$13.6B	-$2.94B	-17.8%	Jun 30, 2021	10-Q	2021-08-09
Q1 2021	$14.4B	-$1.7B	-10.5%	Mar 31, 2021	10-Q	2021-05-05
Q4 2020	$14.1B	-$95M	-0.67%	Dec 31, 2020	10-K	2022-02-25
Q3 2020	$16.7B	+$4.37B	+35.5%	Sep 30, 2020	10-Q	2020-11-05
Q2 2020	$16.6B	+$3.19B	+23.8%	Jun 30, 2020	10-Q	2020-08-05
Q1 2020	$16.1B	+$5.1B	+46.3%	Mar 31, 2020	10-Q	2020-05-06
Q4 2019	$14.2B	+$1.09B	+8.33%	Dec 31, 2019	10-K	2021-02-25
Q3 2019	$12.3B	+$132M	+1.08%	Sep 30, 2019	10-Q	2019-11-05
Q2 2019	$13.4B	+$483M	+3.75%	Jun 30, 2019	10-Q	2019-08-06
Q1 2019	$11B	-$2.5B	-18.5%	Mar 31, 2019	10-Q	2019-05-08
Q4 2018	$13.1B	-$1.08B	-7.61%	Dec 31, 2018	10-K	2020-02-26
Q3 2018	$12.2B	-$2.96B	-19.6%	Sep 30, 2018	10-Q	2018-11-06
Q2 2018	$12.9B	-$3.22B	-20%	Jun 30, 2018	10-Q	2018-08-07
Q1 2018	$13.5B	-$3.36B	-19.9%	Mar 31, 2018	10-Q	2018-05-08
Q4 2017	$14.2B	-$3.12B	-18%	Dec 31, 2017	10-K	2019-02-27
Q3 2017	$15.1B	-$5.37B	-26.2%	Sep 30, 2017	10-Q	2017-11-07
Q2 2017	$16.1B	-$4.2B	-20.7%	Jun 30, 2017	10-Q	2017-08-08
Q1 2017	$16.9B	-$4.5B	-21.1%	Mar 31, 2017	10-Q	2017-05-09
Q4 2016	$17.3B	-$5.3B	-23.4%	Dec 31, 2016	10-K	2018-02-27
Q3 2016	$20.5B	-$3.22B	-13.6%	Sep 30, 2016	10-Q	2016-11-07
Q2 2016	$20.3B	-$4.44B	-17.9%	Jun 30, 2016	10-Q	2016-08-08
Q1 2016	$21.4B	-$4.72B	-18.1%	Mar 31, 2016	10-Q	2016-05-09
Q4 2015	$22.6B	+$2.22B	+10.9%	Dec 31, 2015	10-K	2017-02-28
Q3 2015	$23.7B	+$3.33B	+16.3%	Sep 30, 2015	10-Q	2015-11-05
Q2 2015	$24.8B	+$5.92B	+31.4%	Jun 30, 2015	10-Q	2015-08-06
Q1 2015	$26.1B	+$5.56B	+27.1%	Mar 31, 2015	10-Q	2015-05-07
Q4 2014	$20.4B	-$3.42B	-14.3%	Dec 31, 2014	10-K	2016-02-26
Q3 2014	$20.4B	-$4.61B	-18.4%	Sep 30, 2014	10-Q	2014-11-10
Q2 2014	$18.8B	-$7.5B	-28.5%	Jun 30, 2014	10-Q	2014-08-07
Q1 2014	$20.5B	-$7.59B	-27%	Mar 31, 2014	10-Q	2014-05-08
Q4 2013	$23.8B	-$5.28B	-18.2%	Dec 31, 2013	10-K	2015-02-27
Q3 2013	$25B	-$5.32B	-17.6%	Sep 30, 2013	10-Q	2013-11-07
Q2 2013	$26.3B	-$5.29B	-16.7%	Jun 30, 2013	10-Q	2013-08-07
Q1 2013	$28.1B	-$4.89B	-14.8%	Mar 31, 2013	10-Q	2013-05-09
Q4 2012	$29.1B	-$5.22B	-15.2%	Dec 31, 2012	10-K	2014-02-27
Q3 2012	$30.3B	-$5.5B	-15.3%	Sep 30, 2012	10-Q	2012-11-09

Previous1 2Next

Showing 1 to 50 of 60 entries

* An asterisk sign (*) next to the value indicates that the value is likely invalid.